Juvena Therapeutics is a biotech company accelerating the development of therapeutics by unlocking the therapeutic potential of secreted proteins. Secreted proteins are a class of biologics with proven therapeutic potential that has been under-leveraged due to the complexity of identifying and screening such proteins. The company is developing a patent-pending computational drug discovery and development platform that is delivering novel biologics to address major unmet medical needs in chronic and age-related diseases by mining regenerative proteins secreted by stem cells.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/08/22 | $41,000,000 | Series A |
Alumni Ventures Group Bison Ventures BoxOne Ventures Compound Felicis Ventures Horizons Ventures  Intersect VC IRONGREY Jeff Dean Karl Pfleger Manta Ray Ventures Mubadala Capital Plum Alley Investments Transform Capital | undisclosed |
